ArticleObesity surgery2015
Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source.
Article in Obesity surgery, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 28 citations in OpenAlex.
- Impact of body mass index on the efficacy of acupuncture treatment of postprandial distress syndrome: secondary analysis of a randomized clinical trial.Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2026Trial
- Dietary Modifications in IBS Leads to Reduced Symptoms, Weight, and Lipid Levels: Two Randomized Clinical Trials.Nutrients · 2025Trial
- Prevalence of constipation in adults with obesity class II and III and associated factors.BMC gastroenterology · 2021Trial
- Consequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric Surgery.Obesity surgery · 2017Trial
- Disorders of the gut-brain interaction among European people with obesity: Prevalence and burden of compatible symptoms.United European gastroenterology journal · 2025Article
- Overweight and vitamin D deficiency are common in patients with irritable bowel syndrome - a cross-sectional study.BMC gastroenterology · 2024Article
- Obesity Contributes to Inflammation in Patients with IBS via Complement Component 3 and C-Reactive Protein.Nutrients · 2022Article
- Benign Anorectal Disorders and Pelvic Floor Disease After Bariatric Surgery.Journal of clinical medicine research · 2022Review
- Association Between Body Mass Index and Functional Dyspepsia in Young Japanese People.Journal of neurogastroenterology and motility · 2022Article
- Discovery of Drug Candidates for Specific Human Disease Based on Natural Products of Gut Microbes.Frontiers in microbiology · 2022Article
- Article
- Animal Models for Functional Gastrointestinal Disorders.Frontiers in psychiatry · 2020Review
- Irritable bowel syndrome-like symptoms and health related quality of life two years after Roux-en-Y gastric bypass - a prospective cohort study.BMC gastroenterology · 2019Article
- Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects.Journal of neurogastroenterology and motility · 2019Article
- The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity.PloS one · 2018Article
- Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional study.BMC obesity · 2017Article
- Prevalence of Irritable Bowel Syndrome in Singapore and Its Association with Dietary, Lifestyle, and Environmental Factors.Journal of neurogastroenterology and motility · 2016Article
- The Effects of Bariatric Procedures on Bowel Habit.Obesity surgery · 2016Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObesity is frequently associated to many functional gastrointestinal disorders. The aim of the present study was to assess the prevalence of functional gastrointestinal disorders in obese patients, according to their body mass index and their recruitment source.
methodsFive hundred ninety-six obese patients (body mass index (BMI) > 30) filled out a standard questionnaire in order to evaluate the presence of functional gastrointestinal disorders. They were divided into four groups according to the Rome III criteria and their BMI: OF, obese patients from functional gastrointestinal disorder (FGID) enrollment; OO, obese patients from obesity management enrollment; MF, morbid obesity patients from FGID enrollment; and MO, morbid obesity patients from obesity management enrollment. Data analysis was performed using multivariate logistic regression.
resultsOut of the 596 obese patients included in the present study, 183 (33 %) were complaining of FGIDs, while 413 (67 %) were consulting for obesity management. Compared to the OF group, the OO patients had a higher prevalence of females (P = 0.008) and a younger age (P < 0.001). Clinically, they reported a lower incidence of regurgitation (P = 0.044), of chest pain (P = 0.004), of irritable bowel syndrome (IBS; P = 0.035), and of functional diarrhea (P = 0.030). Compared to the MF group, the MO patients had an older age (P = 0.001), a higher BMI (P = 0.013), and clinically by a high frequency of functional dyspepsia (P = 0.006). There were symptoms that had similar prevalence in all groups (OF, OO, MF, MO) such as epigastric pain, postprandial distress, constipation, diarrhea, bloating, abdominal pain soiling, or nonspecific anorectal disorders.
conclusionsThis study has shown that the recruitment source accounted for marked and specific differences in the prevalence of functional gastrointestinal disorders in obesity and morbid obesity. Symptoms with similar prevalence in all groups should be systematically detected in all patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.